Clinical trial
New Daily Persistent Headache (NDPH): Biomarker Study and Therapy in Children and Adolescents
NCT06018025 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Daily Persistent Headache (NDPH): Biomarker Study and Therapy in Children and Adolescents
- Lead sponsor
- Duke University
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 15, 2024
- Completion date
- May 29, 2025
- Enrollment
- 38 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
new persistent daily headache